Combining ALK Fluorescent In Situ Hybridization and Immunohistochemistry to Analyze Multiple Non-Small Cell Lung Carcinoma Samples per Patient Reveals Intermethod and Intersample-discrepant Results. [electronic resource]
Producer: 20200723Description: 565-571 p. digitalISSN:- 1533-4058
- Adult
- Aged
- Aged, 80 and over
- Anaplastic Lymphoma Kinase -- antagonists & inhibitors
- Antineoplastic Agents -- therapeutic use
- Carcinoma, Non-Small-Cell Lung -- diagnosis
- Crizotinib -- therapeutic use
- Female
- Humans
- Immunohistochemistry -- methods
- In Situ Hybridization, Fluorescence -- methods
- Lung Neoplasms -- diagnosis
- Male
- Middle Aged
- Protein Kinase Inhibitors -- therapeutic use
- Retrospective Studies
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.